DE3667469D1 - Basische monocarboxylamid-derivate des actagardines mit antibiotischer wirkung. - Google Patents

Basische monocarboxylamid-derivate des actagardines mit antibiotischer wirkung.

Info

Publication number
DE3667469D1
DE3667469D1 DE8686103296T DE3667469T DE3667469D1 DE 3667469 D1 DE3667469 D1 DE 3667469D1 DE 8686103296 T DE8686103296 T DE 8686103296T DE 3667469 T DE3667469 T DE 3667469T DE 3667469 D1 DE3667469 D1 DE 3667469D1
Authority
DE
Germany
Prior art keywords
actagardine
derivatives
basic
functions
atcc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686103296T
Other languages
English (en)
Inventor
Adriano Malabarba
Bruno Cavalleri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Application granted granted Critical
Publication of DE3667469D1 publication Critical patent/DE3667469D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8686103296T 1985-03-22 1986-03-12 Basische monocarboxylamid-derivate des actagardines mit antibiotischer wirkung. Expired - Fee Related DE3667469D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858507528A GB8507528D0 (en) 1985-03-22 1985-03-22 Basis monocarboxyamide derivatives

Publications (1)

Publication Number Publication Date
DE3667469D1 true DE3667469D1 (de) 1990-01-18

Family

ID=10576477

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686103296T Expired - Fee Related DE3667469D1 (de) 1985-03-22 1986-03-12 Basische monocarboxylamid-derivate des actagardines mit antibiotischer wirkung.

Country Status (13)

Country Link
US (1) US4684644A (de)
EP (1) EP0195359B1 (de)
JP (1) JPS61227529A (de)
KR (1) KR860007201A (de)
AT (1) ATE48608T1 (de)
CA (1) CA1259985A (de)
DE (1) DE3667469D1 (de)
DK (1) DK165120C (de)
ES (1) ES8705893A1 (de)
GB (1) GB8507528D0 (de)
HU (1) HU199510B (de)
IL (1) IL78181A0 (de)
ZA (1) ZA861424B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8711066D0 (en) * 1987-05-11 1987-06-17 Lepetit Spa Teicoplanin derivatives
DE19745583A1 (de) * 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0900599D0 (en) 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
RS53586B1 (en) * 2009-01-14 2015-02-27 Novacta Biosystems Limited DERIVATION OF DECISION
SG173504A1 (en) * 2009-02-04 2011-09-29 Novacta Biosystems Ltd Actagardine derivatives
CA2789164A1 (en) 2010-02-02 2011-08-11 Novacta Biosystems Limited Lantibiotic salts
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013508D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
GB201013509D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013507D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
CN102993188A (zh) * 2012-11-03 2013-03-27 浙江大学 弗霉素b及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1470407A (en) * 1974-07-27 1977-04-14 Lepetit Spa Antibiotic substances

Also Published As

Publication number Publication date
IL78181A0 (en) 1986-07-31
HU199510B (en) 1990-02-28
CA1259985A (en) 1989-09-26
EP0195359A3 (en) 1987-12-09
ATE48608T1 (de) 1989-12-15
DK123386A (da) 1986-09-23
DK123386D0 (da) 1986-03-18
ZA861424B (en) 1986-12-30
JPS61227529A (ja) 1986-10-09
DK165120C (da) 1993-03-01
US4684644A (en) 1987-08-04
EP0195359A2 (de) 1986-09-24
EP0195359B1 (de) 1989-12-13
KR860007201A (ko) 1986-10-08
HUT40455A (en) 1986-12-28
ES8705893A1 (es) 1987-05-16
ES553227A0 (es) 1987-05-16
GB8507528D0 (en) 1985-05-01
DK165120B (da) 1992-10-12

Similar Documents

Publication Publication Date Title
DE3667469D1 (de) Basische monocarboxylamid-derivate des actagardines mit antibiotischer wirkung.
CA2258906A1 (en) Amides
DE69432758D1 (en) Therapeutisch wirksame peptidderivate
ES8103171A1 (es) Un procedimiento de preparacion de monacolina k.
ES2035260T3 (es) Cepa de microorganismos con actividad antimicrobiana.
GR3005344T3 (de)
MY129859A (en) Bacterial strains of the bacterium bacillus thuringiensis and uses therefor
ES2010729A6 (es) Un procedimiento para prerparar un des-acil- antibiotico a 40926.
MXPA06000691A (es) Antibiotico 107891, sus factores a1 y a2, sales y composiciones farmaceuticamente aceptables y uso de las mismas.
ATE23362T1 (de) Antibiotische verbindung.
CA2169051A1 (en) Rye-Flour
RU94027279A (ru) Агент для ограничения роста бактерий в средах спиртовой ферментации
ES8102590A1 (es) Metodo de producir antibioticos del tipo basado en streptomyces.
DE3377798D1 (de) Nargenicin c1
AU1681788A (en) Bacillus thuringiensis P-2 toxin gene, protein and related insecticide compositions
IT1248095B (it) Ceppi batterici di pseudomonas (ncimb 40403, ncimb 40376, ncimb 40375,ncimb 40377, ncimb 40402, ncimb 40379) in grado di controllare le infezioni fungine.
MD1105C2 (ro) N-(5-Nitro-2-furfuriliden)-4-aminobenzensulfamide, care manifestă activitate antimicrobiană
KR960029769A (ko) 배추흰나비(Pieris rapae) 유충으로부터 분리한 신규한 항균단백질
JPS5350395A (en) Preparation of antibiotics colstine
ES479116A1 (es) Procedimiento para la obtencion de una mezcla de antibioti- cos bm782 alfaii, bm782 alfa 2 y bm782 alfa ia.
NO930834L (no) Anvendelse av et 2-deoksystreptamin-type antibiotikum
JPS57132887A (en) Antibiotic s/433

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee